BDBM387113 5-[(3aR, 7aR)-6-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}octahydro-1H- pyrrolo[2,3-c]pyridin-1-yl]-1,6-naphthyridine::US9938276, B8

SMILES O=C(N1CC[C@H]2CCN([C@H]2C1)c1nccc2ncccc12)c1ccccc1-n1nccn1

InChI Key InChIKey=AKKFTJMMQKTTBT-JTSKRJEESA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 387113   

TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387113(5-[(3aR, 7aR)-6-{[2-(2H-1,2,3-triazol-2- yl)phenyl...)
Affinity DataIC50:  1.00E+4nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387113(5-[(3aR, 7aR)-6-{[2-(2H-1,2,3-triazol-2- yl)phenyl...)
Affinity DataIC50:  2.52E+3nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent